Abstract:OBJECTIVE:Adult stem cell senescence and exhaustion are important drivers of organismal age. Restored stem cell self-renewal has revealed novel therapeutic targets for decreasing the incidence of age-associated diseases (AADs) and prolonging the human health span. Transient ectopic expression of the reprogramming factors Oct3/4, Sox2, Klf4 and c-Myc (collectively known as OSKM) in somatic cells can induce partial cellular reprogramming and effectively ameliorate their age-associated hallmarks. However, how this form of rejuvenation is applied to senescent stem cells remains unknown.MATERIALS AND METHODS:The Integrin-α6highCD71high epidermal stem cells (ESCs) with low self-renewal ability were sorted by flow cytometry and then treated by the interrupted reprogramming induced by transient expression of OSKM. The ability of secondary clones' generation and self-proliferation in vitro, as well as stem cell marker p63, were detected to determine their self-renewal ability. Besides, gene and protein of epidermal cell markers were detected to determine whether their cell identities were retained. Finally, DNA methylation age (eAge) and DNA dehydroxymethylase/methyltransferase were analyzed to explore the alternation of their global DNA methylation pattern during this rejuvenation.RESULTS:The partial reprogramming restored the youthful self-renewal and proliferation in senescent ESCs, including larger secondary clone generation, higher expression of stem cell marker p63 and proliferation marker Ki67, and faster proliferation speed, in each case without abolishing epithelial cellular identity. Moreover, the rejuvenation of adult stem cells could be maintained for 2 weeks after reprogramming factor withdrawal, which was more stable than that of differentiated somatic cells. Additionally, we found that partial reprogramming counteracted the acceleration of eAge in senescent epidermal stem cells and DNA methyltransferase 1 (DNMT1) may play a crucial role in this process.CONCLUSIONS:Partial reprogramming has high therapeutic potential for reversing adult stem cell age, providing an advanced way to treat AADs.

Partial Reprogramming as a Method for Regenerating Neural Tissues in Aged Organisms

The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders

The long and winding road of reprogramming-induced rejuvenation

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Direct Reprogramming in Bone and Joint Degenerative Diseases: Applications, Obstacles and Directions

Neuron-specific partial reprogramming in the dentate gyrus impacts mouse behavior and ameliorates age-related decline in memory and learning.

Remodeling Neurodegeneration: Somatic Cell Reprogramming-Based Models of Adult Neurological Disorders

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

Next-generation direct reprogramming

Transcriptomic reprogramming for neuronal age reversal

Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice

Epigenetic rejuvenation by partial reprogramming

Partial Cellular Reprogramming Stably Restores the Stemness of Senescent Epidermal Stem Cells.

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration

In vivo cyclic overexpression of Yamanaka factors restricted to neurons reverses age-associated phenotypes and enhances memory performance

Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells

Enhanced Rejuvenation in Induced Pluripotent Stem Cell-Derived Neurons Compared with Directly Converted Neurons from an Aged Mouse

In vivo reprogramming of leads to heterogeneous effects on lifespan

Manipulating cell fate through reprogramming: approaches and applications